HIV Infection and Long‐Term Residual Cardiovascular Risk After Acute Coronary Syndrome
Open Access
- 1 September 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 9 (17)
- https://doi.org/10.1161/jaha.119.017578
Abstract
Background It is unclear whether HIV infection affects the long‐term prognosis after an acute coronary syndrome (ACS). The objective of the current study was to compare rates of major adverse cardiac and cerebrovascular events after a first ACS between people living with HIV (PLHIV) and HIV‐uninfected (HIV−) patients, and to identify determinants of cardiovascular prognosis. Methods and Results Consecutive PLHIV and matched HIV− patients with a first episode of ACS were enrolled in 23 coronary intensive care units in France. Patients were matched for age, sex, and ACS type. The primary end point was major adverse cardiac and cerebrovascular events (cardiac death, recurrent ACS, recurrent coronary revascularization, and stroke) at 36‐month follow‐up. A total of 103 PLHIV and 195 HIV− patients (mean age, 49 years [SD, 9 years]; 94.0% men) were included. After a mean of 36.6 months (SD, 6.1 months) of follow‐up, the risk of major adverse cardiac and cerebrovascular events was not statistically significant between PLHIV and HIV− patients (17.8% and 15.1%, P=0.22; multivariable hazard ratio [HR], 1.60; 95% CI, 0.67–3.82 [P=0.29]). Recurrence of ACS was more frequent among PLHIV (multivariable HR, 6.31; 95% CI, 1.32–30.21 [P=0.02]). Stratified multivariable Cox models showed that HIV infection was the only independent predictor for ACS recurrence. PLHIV were less likely to stop smoking (47% versus 75%; P=0.01) and had smaller total cholesterol decreases (–22.3 versus –35.0 mg/dL; P=0.04). Conclusions Although the overall risk of major adverse cardiac and cerebrovascular events was not statistically significant between PLHIV and HIV− individuals, PLHIV had a higher rate of recurrent ACS. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT00139958.Keywords
This publication has 26 references indexed in Scilit:
- Outcomes After Acute Myocardial Infarction in HIV-Infected PatientsCirculation, 2013
- HIV and Coronary Heart DiseaseJournal of the American College of Cardiology, 2013
- Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary SyndromeThe American Journal of Cardiology, 2013
- Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapyEuropean Heart Journal, 2011
- Clinical presentation of acute coronary syndrome in HIV infected adults: A retrospective analysis of a prospectively collected cohortEuropean Journal of Internal Medicine, 2011
- Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosisEuropean Heart Journal, 2010
- Comparison of Outcomes Using Bare Metal Versus Drug-Eluting Stents in Coronary Artery Disease Patients With and Without Human Immunodeficiency Virus InfectionThe American Journal of Cardiology, 2009
- Mortality after myocardial infarction in HIV-infected patients who have initiated HAARTAIDS, 2007
- Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus InfectionCirculation, 2004
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiology CommitteeJournal of the American College of Cardiology, 2000